Skip to main content
Have a personal or library account? Click to login
Evaluation of Diet Supplementation with a Product Based on Honey and Sea Buckthorn (Hebe - Melinis) on Quality of Life and Gastrointestinal Dysfunction in Patients with Parkinson’s Disease Cover

Evaluation of Diet Supplementation with a Product Based on Honey and Sea Buckthorn (Hebe - Melinis) on Quality of Life and Gastrointestinal Dysfunction in Patients with Parkinson’s Disease

By:   
Open Access
|Jul 2026

References

  1. Tysnes OB, Storstein A. Epidemiology of Parkinson’s disease. JNeural Transm (Vienna). 2017;124(8):901–905.
  2. Cooper G, Eichhorn G, Rodnitzky RL (2008). “Parkinson’s disease”. In Conn PM (ed.). Neuroscience in medicine. Humana Press. ISBN 978-1-6032-7454-8.
  3. Garcia-Ruiz PJ, Chaudhuri KR, Martinez-Martin P. Non-motor symptoms of Parkinson’s disease A review… from the past. J Neurol Sci. 2014;338(1-2):30–33.
  4. Prasuhn J, Piskol L, Vollstedt EJ, et al. Non-motor symptoms and quality of life in subjects with mild parkinsonian signs. Acta Neurol Scand. 2017;136(5):495–500.
  5. Leonardi M, Raggi A, Pagani M, Carella F, Soliveri P, Albanese A, Romito L, (2012), Relationships between disability, quality of life and prevalence of nonmotor symptoms in parkinson’s disease, Parkinsonism Relat Disord. Jan. Vol 18 (1); 35-39
  6. Chapuis S, Ouchchans L, Metz O, Gerbaud L, Durif F. (2005), Impact of the motor complications of Parkinson’s disease on the quality of life. Mov Disord; 20: 224–30.
  7. Bloem BR, Okun MS, Klein C: Parkinson’s disease. Lancet. 2021, 397:2284-2303. 10.1016/S0140-6736(21)00218-X
  8. Klann EM, Dissanayake U, Gurrala A, Farrer M, Shukla AW, Ramirez-Zamora A, Mai V and Vedam-Mai V (2022) The Gut– Brain Axis and Its Relation to Parkinson’s Disease: A Review. Front. Aging Neurosci. 13:782082. doi: 10.3389/fnagi.2021.782082
  9. Tan, A.H., Lim, S.Y. & Lang, A.E. The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic. Nat Rev Neurol 18, 476–495 (2022). https://doi.org/10.1038/s41582-022-00681-2
  10. Morais, L. H., Schreiber, H. L. & Mazmanian, S. K. The gut microbiota–brain axis in behaviour and brain disorders. Nat. Rev. Microbiol. 19, 241–255 (2021).
  11. WHO. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403–1409.
  12. David J. Sanders, Saskia Inniss, Gregory Sebepos-Rogers, Farooq Z. Rahman, Andrew M. Smith; The role of the microbiome in gastrointestinal inflammation. Biosci Rep 28 May 2021; 41 (6): BSR20203850. doi: https://doi.org/10.1042/BSR20203850
  13. Kwon D, Zhang K, Paul KC, Folle AD, Del Rosario I, Jacobs JP, Keener AM, Bronstein JM, Ritz B. Diet and the gut microbiome in patients with Parkinson’s disease. NPJ Parkinsons Dis. 2024 Apr 22;10(1):89. doi: 10.1038/s41531-024-00681-7. PMID: 38649365; PMCID: PMC11035608.
  14. Hasan N, Yang H. Factors affecting the composition of the gut microbiota, and its modulation. PeerJ. 2019 Aug 16;7:e7502. doi: 10.7717/peerj.7502. PMID: 31440436; PMCID: PMC6699480.
  15. Scott, K. P., Jean-Michel, A., Midtvedt, T., & van Hemert, S. (2015). Manipulating the gut microbiota to maintain health and treat disease. Microbial Ecology in Health and Disease, 26(1). https://doi.org/10.3402/mehd.v26.25877
  16. Hughes AJ et al. UK Parkinson’s Disease Society Brain Bank, Clinical Diagnostic Criteria, J Neurol Neurosurg Psychiatry 1992;55:181-4)
  17. Wenning, G.K., Stankovic, I., Vignatelli, L., Fanciulli, A., Calandra-Buonaura, G., Seppi, K., Palma, J.-A., Meissner, W.G., Krismer, F., Berg, D., Cortelli, P., Freeman, R., Halliday, G., Höglinger, G., Lang, A., Ling, H., Litvan, I., Low, P., Miki, Y., Panicker, J., Pellecchia, M.T., Quinn, N., Sakakibara, R., Stamelou, M., Tolosa, E., Tsuji, S., Warner, T., Poewe, W. and Kaufmann, H. (2022), The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy. Mov Disord, 37: 1131-1148. https://doi.org/10.1002/mds.29005
  18. Gibson, G.R.; Hutkins, R.; Sanders, M.E.; Prescott, S.L.; Reimer, R.A.; Salminen, S.J.; Scott, K.; Stanton, C.; Swanson, K.S.; Cani,P.D.; et al. Expert Consensus Document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) Consensus Statement on the Definition and Scope of Prebiotics. Nat. Rev. Gastroenterol. Hepatol. 2017, 14, 491–502. [CrossRef]
  19. Mohan A, Quek S, Gutierrez-Maddox N, Gao Y, Shu Q Author Notes, Effect of honey in improving the gut microbial balance Food Quality and Safety, Volume 1, Issue 2, 1 May 2017, Pages 107–115, https://doi.org/10.1093/fqsafe/fyx015
  20. Ranneh Y, Akim AM, Hamid HA, Khazaai H, Fadel A, Zakaria ZA, et al. Honey and its nutritional and anti-inflammatory value. BMC Complement Med Ther. (2021) 21:30. 10.1186/s12906-020-03170-5
  21. Yue, X.F.; Shang, X.; Zhang, Z.J.; Zhang, Y.N. Phytochemical composition and antibacterial activity of the essential oils from different parts of sea buckthorn (Hippophae rhamnoides L.). J. Food Drug Anal. 2017, 25, 327–332.
  22. Dubey R, Shukla S, Shukla V, Singh S: Sea buckthorn: A Potential Dietary supplement with multifaceted therapeutic activities; Intelligent Pharmacy, Available online 22 December 2023 https://doi.org/10.1016/j.ipha.2023.12.003
  23. Wang Z, Zhao F, Wei P, Chai X, Phytochemistry, health benefits, and food applications of sea buckthorn (Hippophae rhamnoides L.): A comprehensive review, Front Nutr. 2022; 9: 1036295. Published online 2022 Dec 6. doi: 10.3389/fnut.2022.1036295
  24. Rudrapal M, Khairnar SJ, Khan J, Dukhyil AB, Ansari MA, Alomary MN, Alshabrmi FM, Palai S, Deb PK, Devi R. Dietary Polyphenols and Their Role in Oxidative Stress-Induced Human Diseases: Insights Into Protective Effects, Antioxidant Potentials and Mechanism(s) of Action. Front Pharmacol. 2022 Feb 14;13:806470. doi: 10.3389/fphar.2022.806470. PMID: 35237163; PMCID: PMC8882865.
  25. Joseph J, Cole G, Head E, Ingram D, Nutrition, Brain Aging, and Neurodegeneration, Journal of Neuroscience 14 October 2009, 29 (41) 12795-12801; DOI: 10.1523/JNEUROSCI. 3520-09.2009
  26. Jenner P. Oxidative stress in Parkinson’s disease. Ann Neurol. 2003;53 Suppl 3:S26-36; discussion S36-8. doi: 10.1002/ana.10483. PMID: 12666096.
  27. Cryan JF, O’riordan KJ, Sandhu K, Peterson V, Dinan TG. The Gut Microbiome in Neurological Disorders. Lancet Neurol (2020) 19(2):179–94. doi: 10.1016/s1474-4422(19)30356-4
  28. Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett. 2006 Mar 20;396(1):67-72. doi: 10.1016/j.neulet.2005.11.012. Epub 2005 Dec 5. PMID: 16330147.
  29. Fadzil, M.A.M.; Mustar, S.; Rashed, A.A. The Potential Use of Honey as a Neuroprotective Agent for the Management of Neurodegenerative Diseases. Nutrients 2023, 15, 1558. https://doi.org/10.3390/nu15071558
  30. Rajendran PR, Thompson RE, Reich SG. The use of alternative therapies by patients with Parkinson’s disease. Neurology 2001;57:790–794.
  31. So, Y.-J.; Lee, J.-U.; Yang, G.-S.; Yang, G.; Kim, S.-W.; Lee, J.-H.; Kim, J.-U. The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson’s Disease: A Promising Therapeutic Approach. Int. J. Mol. Sci. 2024, 25, 1071. https://doi.org/10.3390/ijms25021071
  32. Rabin ML, Stevens-Haas C, Havrilla E, Rosenstein A, Toffey B, Devi T, Earnhardt MC, Kurlan R. Complementary Therapies for Parkinson’s Disease: What’s Promoted, Rationale, Potential Risks and Benefits. Mov Disord Clin Pract. 2015 Jun 29;2(3):205-212. doi: 10.1002/mdc3.12170. PMID: 30363487; PMCID: PMC6178661.
  33. Iftikhar A, Nausheen R, Muzaffar H, Naeem MA, Farooq M, Khurshid M, Almatroudi A, Alrumaihi F, Allemailem KS, Anwar H. Potential Therapeutic Benefits of Honey in Neurological Disorders: The Role of Polyphenols. Molecules. 2022 May 20;27(10):3297. doi: 10.3390/molecules27103297. PMID: 35630774; PMCID: PMC9143627.
  34. Yildiz, O.K.T.A.Y.; Karahalil, F.A.T.M.A.; Can, Z.; Sahin, H.; Kolayli, S.E.V.G.İ. Total monoamine oxidase (MAO) inhibition by chestnut honey, pollen and propolis. J. Enzym. Inhib. Med. Chem. 2014, 29, 690–694
  35. Chen Y, Cai Y, Wang K, Wang Y. Bioactive Compounds in Sea Buckthorn and their Efficacy in Preventing and Treating Metabolic Syndrome. Foods. 2023 May 13;12(10):1985. doi: 10.3390/foods12101985. PMID: 37238803; PMCID: PMC10217465.
  36. Ranjith A., Kumar K.S., Venugopalan V.V., Arumughan C., Sawhney R.C., Singh V. Fatty acids, tocols, and carotenoids in pulp oil of three sea buckthorn species (Hippophae rhamnoides, H. salicifolia, and H. tibetana) grown in the Indian Himalayas. J. Am. Oil Chem. Soc. 2006;83:359–364. doi: 10.1007/s11746-006-1213-z.
DOI: https://doi.org/10.2478/arsm-2026-0005 | Journal eISSN: 1841-4036 | Journal ISSN: 1223-9666
Language: English
Page range: 24 - 32
Published on: Jul 11, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Ioan Buraga, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution 4.0 License.